Essential fatty acid composition
AssigneeEfamol Holdings PLC
InventorDavid F. Horrobin
Life of this patent
Estimating the term…
Abstract
Treatment or prevention of memory loss with a medicament consisting of an n-6 essential fatty acid selected from GLA, DGLA, AA, adrenic acid and the 22:5 n-6 acid and an n-3 essential fatty acid selected from the 18:4 n-3 and 20:4 n-3 acids, EPA, the 22:5 n-3 acid and DHA.
Claims2
A method of improving memory comprising administering to a person suffering from deterioration of memory associated with schizophrenia or with physiological aging as measured by the Sterling or Weschler tests, an n-6 essential fatting acid selected from GLA, DGLA, AA, adrenic acid and the 22:5 n-6 acid and an n-3 essential fatty acid selected from the 18:4 n-3 and 20:4 n-3 acids, EPA, the 22:5 n-3 acid and DHA in an effective amount of each of the n-6 acid and the n-3 acid of 1 mg to 100 g per day.
Dependencies are inferred from the claim text.